TiLOOP®Bra

Matrice bioinerte titanizzata presagomata per la chirurgia ricostruttiva del seno

In presenza di una neoformazione maligna della mammella e spesso anche quando c’è un forte rischio che si sviluppi un tumore vengono eseguiti interventi demolitivi di vario tipo, in rapporto allo sviluppo della malattia e alla strategia terapeutica prescelta.
La ricostruzione può essere immediata cioè eseguita durante lo stesso intervento demolitivo oppure può essere differita e cioè eseguita in un secondo tempo, a distanza di 6-9 mesi dopo il primo intervento.

La mesh TiLoop BRA® commercializzata dalla Sunmedical è l’unica rete sintetica sul mercato approvata appositamente per la ricostruzione del seno dopo mastectomia. Il rivestimento in titanio aumenta notevolmente la biocompatibilità con i tessuti ed è proprio per questa sua caratteristica che da decenni è impiegato in altre branche della medicina.

Essa consente di posizionare la protesi mammaria immediatamente dopo la rimozione della massa tumorale evitando così il posizionamento dell’espansore temporaneo e successivamente, del secondo intervento.

La mesh viene ancorata al muscolo pettorale e quindi rivolta su stessa andando ad “impacchettare” la protesi mammaria. Il rivestimento brevettato in Titanio e la sua leggerezza garantiscono un’ottima biocompatibilità ed il massimo comfort per il paziente.

Nell’area download di questa sezione, potrai scaricare sia il video con tecnica Dual plane, sia il video con tecnica sottocutanea con impianto di protesi definitiva.

Codice	Descrizione	Pz./Conf.
6000636	TiLOOP® small 16 g/m² (extralight)	1
6000637	TiLOOP® medium 16 g/m² (extralight)	1
6000638	TiLOOP® large 16 g/m² (extralight)	1

Scarica il video per poterlo consultare offline.

Contattaci per avere informazioni sul prodotto e ordinarlo

Compila il form

Chiamaci

T +39 02 87282900

Stampa

Benefici della procedura

Prodotto unico
Ottima biocompatibilità
Rete ultraleggera
Elevata capacità di espansione
Restringimento minimo
Flessibilità appropriata ai tessuti

Applicazioni

In tutti i casi di ricostruzione dopo mastectomia sottocutanea dove viene preservata la pelle sovrastante

I bordi in rete tagliati al laser creano estremità in fibra arrotondate che impediscono i microtraumi.

La fibra flessibile, morbida e leggera (solo 16 g/m²) assicura un’ottima biocompatibilità e massimo comfort per la paziente.

La nanotecnologia permette di ottenere uno strato di titanio legato covalentemente dello spessore di 30 nm, che avvolge interamente il tessuto in polipropilene.

Download

Brochure TiLOOP Bra (1.11 Mb - pdf)

Approfondimenti scientifici

Breast reconstruction with TiLOOP® Bra: Another arrow in plastic surgeons’ quiver?

2025 - Annachiara Tellarini, Elisa Bascialla, Ferruccio Paganini, Veronica Fasoli, Francesco Buttarelli, Eduardo Paolo Marra, Federico Tamborini, Martina Corno, Danilo Di Giovanna, Roberto Baraziol, Maria Flocchini, Laura Maria Curic , Adriana Tuttolomondo, Sarah Calabrese, Luigi Valdatta

Background:

The use of lower-pole sling products has made immediate breast reconstruction a feasible option in women undergoing skin-nipple sparing and skin-reducing mastectomies. To date, available data on the comparative efficacy of biological and synthetic meshes regarding postoperative complications are scattered and limited.

Study results

A systematic literature search was performed to screen three different databases (PubMed, Web of Sciences, and Embase) using the following keywords: “breast reconstruction” AND “TiLOOP®” OR “Titanium-Coated Polypropylene Mesh” OR “TCPM”. The perioperative and demographic characteristics of patients, complications profiles, and patient-reported outcomes were considered.

We initially identified 234 articles, of which only 41, including 3923 patients and 5042 reconstructed breasts, fully satisfied the inclusion criteria

Conclusion:

TiLOOP® Bra could be considered a safe and aesthetically valid alternative to Acellular Dermal Matrices (ADMs) in non-smokers patients undergoing skin-nipple sparing and skin-reducing mastectomies and immediate reconstruction. The incidence of seroma with TiLOOP® Bra is comparable to that of ADMs as it is the beneficial effect in radiated patients, where TiLOOP® Bra seems superior to implant alone reconstruction. It has a good bio-integration with host tissues and resistance to infections in patients with a weakened immune system as a consequence of oncologic perioperative treatments.

Breast reconstruction with TiLOOP® Bra: Another arrow in plastic surgeons’ quiver? (1.11 Mb - pdf)

Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction

2021 - Pietro Gentile, Marco Bernini, Lorenzo Orzalesi, Silvia Sordi, Icro Meattini, Francesca Lessi, Ashutosh Kothari e Claudio Calabrese

Background:

Breast reconstruction is rapidly evolving, thanks to the growing acceptance of synthetic meshes as innovative biomaterials. 276 patients undergoing mastectomy (total of 328 mastectomies) were analyzed in a retrospective observational study to evaluate the pre-pectoral immediate breast reconstruction (IBR) using an implant wrapped with Titanium-Coated Polypropylene Mesh (TCPM) vs. patients treated with tissue expander (TE), equally placed pre-pectorally (and wrapped with the same TCPM in 74.3% of the control group’ breasts).

Study results

Histological analysis showed a process of normal tissue repair with a complete mesh integration and normal healing. Conservative mastectomies with pre-pectoral IBR assisted by TCPM proved themselves oncologically safe, biologically integrated into native tissues, and highly accepted in terms of quality of life guaranteeing a more natural and aesthetic breast appearance.

Conclusion:

This retrospective observational study provided clinical and histological outcomes of the pre-pectoral IBR using an implant wrapped with TCPM vs. patients treated with TE, equally placed pre-pectorally.

All the histological analyses performed confirmed the TCPM mesh complete integration with the physiological aspects of healing: The Collagen 1 and 3 expressions did not differ, between TCPM and NO TCPM samples to confirm a process of healing overlapping to perfect device incorporation and normal healing.

Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction (7.71 Mb - pdf)

Robot-Assisted Nipple-Sparing Mastectomy and Immediate Reconstruction with Prepectoral Tiloop-Enveloped Implant: A Case Report

2021 - Mariotti Carlo, Raffaeli Eugenia, Liverotti Sara, Lenti Enrico, Braccioni Francesco, Gentili Marco, Carrara Maria Cristina and Cardinali Chiara

Background:

This paper describes the first experience our centre had with robot-assisted nipple-sparing mastectomy, which was performed for prophylactic purposes using the Da Vinci Si robotic Surgical System.

Study results

This preliminary experience was very positive as to the accuracy of surgical manoeuvres thanks to the high quality of the 3D image; the demolition and reconstruction operations (carried out using a prepectoral implant covered with a Tiloop Bra synthetic mesh) were performed through a single axillary incision of just a few centimeters.

Conclusion:

The technical difficulties are undeniable, but the learning curves described in the literature are promising

Robot-Assisted -tiloop – Sunmedical (242.02 Kb - pdf)

Veritas in Immediate Implant-based Breast Reconstruction Is Associated with Higher Complications Compared with TiLOOP BRA

2020 - Gaik Si Quah, James R. French, Annelise Cocco, Jeremy Hsu, Farid Meybodi, Elisabeth Elder

Background: Biologic and synthetic meshes are used in immediate implant-based breast reconstruction for coverage of the lower pole of the implant. This study aimed to compare outcomes of Veritas with TiLOOP bra

Study results

Comparison of the Veritas group with the TiLOOP® Bra Group:
- Overall higher complication rate in the Veritas group: 54% vs. 14% of breasts

- Higher seroma rate/ non-integration in the Veritas group: 51.4% vs. 1.6% of breasts

- More implant rotations in the Veritas group: 16.2% vs. 1.1% of breasts

- Higher infection rate in the Veritas group: 18.9% vs. 2.1% of breasts

- More wound dehiscence in the Veritas group: 10.8% vs. 0.5% of breasts

Study 2020 Veritas vs TiLOOP bra (232.22 Kb - pdf)